This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Oncology, Other  • Quality of Life  • Genetics  • Genetics, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Tracy Hampton, PhD

JAMA. 2004;292:673-674.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New Orleans—Although extending life is clearly a primary goal in treating patients with cancer, concerns about quality of life are often considered equally important. In recent years, scientists have discovered that the genetic mutations found in a patient's tumor can often determine the severity of the disease and the potential for a successful response to certain therapies. Now they are finding that a patient's genetic makeup may also play a role in aspects of quality of life—such as a patient's distress, outlook, and fatigue—following treatment.

Scientists are finding that an individual's genetic makeup may play a role in aspects of quality of life—such as levels of fatigue—following cancer chemotherapy. (Photo credit: http://www.sciencesource.com)

At the American Society of Clinical Oncology annual meeting held here in June, scientists discussed novel research that examined how particular genes may influence a patient's quality of life following chemotherapy. While the . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?